Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

P2 Capital Partners Surges Stake in EPIQ Systems, Inc. (EPIQ) Sending Stock Price Up

As a recent filing with the US Securities and Exchange Commission showed, that P2 Capital Partners has surged its position in EPIQ Systems, Inc. (NASDAQ:EPIQ) to almost 6.1 million shares, from 1.75 million the fund disclosed in its latest 13F. Following the increase, P2 Capital Partners, which is led by Claus Moller, owns 16.9% of the company’s common stock.

EPIQ Systems, Inc. (NASDAQ:EPIQ)

Moreover, P2 Capital’s stake is activist by nature. The fund disclosed in the filing that it planned to acquire a significant stake in the company. Following the increase, P2 Capital stated that if EPIQ Systems, Inc. (NASDAQ:EPIQ) is interested in negotiating a deal to take the company private, some of the funds affiliated with it, might be interested in taking control of the company. Earlier in August and September, P2 Capital discussed with EPIQ’s Board of Directors regarding acquiring the company in a deal worth $20 per share.

EPIQ Systems, Inc. (NASDAQ:EPIQ) is a technology company that engages in integrated technology-enabled solutions for electronic discovery, bankruptcy and class action settlement administration.  The stock of the company gained around 14% since the beginning of the year, and surged by over 6% today, after the disclosure of P2 Capital’s stake.

EPIQ Systems, Inc. (NASDAQ:EPIQ) issued a statement following P2’s disclosure of a significant activist stake. The company said that its Board of Directors has explored a various range of opportunities for the company to increase the shareholder value. The Board also came to a conclusion that P2’s proposal to take the company private, “does not unlock the company’s long-term value, is inadequate from a financial point of view, and is not in the best interest of the company and its shareholders.”

During the second quarter of 2014, Jerrold Fine‘s Charter Oak Partners Management added EPIQ Systems, Inc. (NASDAQ:EPIQ) to its equity portfolio. Charter Oak revealed holding 148,100 shares of the company in its latest 13F. Tigershark Partners, led by Tom Facciola, upped its by 11% during the same period and disclosed ownership of close to 120,900 shares. In addition, Ken Griffin‘s Citadel Investment Group surged its exposure to the company by 140% on the quarter to around 68,900 shares held as of the end of June.

Disclosure: none

Warren Buffett and BillionairesFree Report: Warren Buffett and 12 Billionaires Are Crazy About These 7 Stocks

Let Warren Buffett, David Einhorn, George Soros, and David Tepper WORK FOR YOU. If you want to beat the low cost index funds by an average of 6 percentage points per year look no further than Warren Buffett’s stock picks. That’s the margin Buffett’s stock picks outperformed the market since 2008. In this free report, Insider Monkey’s market beating research team identified 7 stocks Warren Buffett and 12 other billionaires are crazy about. CLICK HERE NOW for all the details.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.